VHL Protein (AA 1-213) (His tag)
-
- Target See all VHL Proteins
- VHL (Von Hippel-Lindau Tumor Suppressor, E3 Ubiquitin Protein Ligase (VHL))
- Protein Type
- Recombinant
- Protein Characteristics
- AA 1-213
-
Origin
- Human
-
Source
- Escherichia coli (E. coli)
- Purification tag / Conjugate
- This VHL protein is labelled with His tag.
- Application
- Western Blotting (WB), SDS-PAGE (SDS), Immunogen (Imm), Positive Control (PC)
- Sequence
- Met1-Asp213
- Characteristics
- Recombinant Von Hippel Lindau Tumor Suppressor (vHL), Prokaryotic expression, Met1-Asp213, N-terminal His Tag
- Purity
- > 80 %
- Top Product
- Discover our top product VHL Protein
-
Von Hippel-Lindau Tumor Suppressor, E3 Ubiquitin Protein Ligase (VHL) (AA 1-172) protein (GST tag)
VHL Origin: Human Host: Wheat germ Recombinant WB, ELISA, AA, AP
Von Hippel-Lindau Tumor Suppressor, E3 Ubiquitin Protein Ligase (VHL) (AA 1-213) protein (His tag)custom-made VHL Origin: Human Host: HEK-293 Cells Recombinant > 90 % as determined by Bis-Tris PAGE, anti-tag ELISA, Western Blot and analytical SEC (HPLC)
Von Hippel-Lindau Tumor Suppressor, E3 Ubiquitin Protein Ligase (VHL) (Transcript Variant 1) protein (Myc-DYKDDDDK Tag)VHL Origin: Human Host: HEK-293 Cells Recombinant > 80 % as determined by SDS-PAGE and Coomassie blue staining AbP, STD
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Comment
-
Isoelectric Point:4.4
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Buffer
- 20 mM Tris, 150 mM NaCl, pH 8.0, containing 1 mM EDTA, 1 mM DTT, 0.01 % SKL, 5 % Trehalose and Proclin300.
- Preservative
- ProClin
- Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- 4 °C,-80 °C
- Storage Comment
- Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
- Expiry Date
- 12 months
-
- Target
- VHL (Von Hippel-Lindau Tumor Suppressor, E3 Ubiquitin Protein Ligase (VHL))
- Alternative Name
- Von Hippel Lindau Tumor Suppressor (VHL Products)
- Background
- HRCA1, RCA1, VHL1, Von Hippel-Lindau Syndrome
- Molecular Weight
- 35kDa
- Pathways
- Tube Formation, Signaling Events mediated by VEGFR1 and VEGFR2, Ubiquitin Proteasome Pathway
-
